Default company panoramic image

Vapogenix is developing a new class of superior non-narcotic analgesics that treat pain at its source.

  • Stage Product In Development
  • Industry Other
  • Location Houston, TX, USA
  • Currency USD
  • Website

Company Summary

Vapogenix is an innovator of superior medicines for preventing and treating localized pain through transforming approved therapeutics into novel products. Our technology is based on new routes of administration for a class of off-patent drugs not previously used for pain, with broad potential to treat many painful disorders without the side effects of narcotics. Our 1st product is a quick acting topical analgesic for procedural pain


  • Default avatar
    Danguole Altman
    President and CEO

    Experienced entrepreneur. Ex-McKinsey. AB Harvard, MBA Yale

  • Default avatar
    Heather Giles, Ph.d.
    Chief Scientific Officer

    20+ years drug development experience at GSK. ex-VP Encysive, Ph.D. Pharmacology University of London

  • Default avatar
    Terry Farmer, Ph.D.
    Director, CMC & Analytical Services

    10+ yrs industry CMC/Analytical experience, ex-Encysive, Ph.D. UTHSC Biochemistry

  • Default avatar
    Clarice Motter, CPA

    10+ yrs CFO, ex-KPMG, MBA UCLA


  • Default avatar
    Michael Blaney, JD Blaney & Associates
    Default avatar
    PKF Texas

Previous Investors

  • Default avatar
    Pamoja Capital